Cargando…
Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome
Colorectal cancer is one of the leading causes of tumor-associated death, and traditional Chinese medicine (TCM) classifies colorectal cancer into various subtypes mainly according to the symptomatic pattern identification (ZHENG). Here, we investigated the difference in metabolic profiles of serum...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546053/ https://www.ncbi.nlm.nih.gov/pubmed/28811829 http://dx.doi.org/10.1155/2017/7382752 |
_version_ | 1783255518575329280 |
---|---|
author | Tao, Fangfang Lü, Ping Xu, Chunbo Zheng, Mengmeng Liu, Wenhong Shen, Minhe Ruan, Shanming |
author_facet | Tao, Fangfang Lü, Ping Xu, Chunbo Zheng, Mengmeng Liu, Wenhong Shen, Minhe Ruan, Shanming |
author_sort | Tao, Fangfang |
collection | PubMed |
description | Colorectal cancer is one of the leading causes of tumor-associated death, and traditional Chinese medicine (TCM) classifies colorectal cancer into various subtypes mainly according to the symptomatic pattern identification (ZHENG). Here, we investigated the difference in metabolic profiles of serum by comparing colorectal cancer subjects with Nondeficiency (ND), Qi deficiency (QD), and Yin deficiency (YD). The ratio of subjects with carcinoembryonic antigen (CEA) was higher in YD pattern, and the ratio of subjects with carbohydrate antigen 19-9 (CA19-9) was higher both in YD and in QD, compared with ND. As a result of metabolomics analysis, twenty-five metabolites displayed differences between QD and ND, while twenty-eight metabolites displayed differences between YD and ND. The downregulated metabolites in QD/ND and YD/ND mainly include carbohydrates and the upregulated metabolites mainly include amino acids and fatty acids, suggesting conversion obstruction of carbohydrates, fatty acids, and amino acids occurs in patients with QD and YD compared with ND. Our results demonstrate that colorectal cancer patients with QD or YD were associated with metabolic disorders and the variations of serum metabolic profiles may serve as potential biochemical markers for diagnosis and prognosis of colorectal cancer patients displayed QD or YD patterns. |
format | Online Article Text |
id | pubmed-5546053 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-55460532017-08-15 Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome Tao, Fangfang Lü, Ping Xu, Chunbo Zheng, Mengmeng Liu, Wenhong Shen, Minhe Ruan, Shanming Evid Based Complement Alternat Med Research Article Colorectal cancer is one of the leading causes of tumor-associated death, and traditional Chinese medicine (TCM) classifies colorectal cancer into various subtypes mainly according to the symptomatic pattern identification (ZHENG). Here, we investigated the difference in metabolic profiles of serum by comparing colorectal cancer subjects with Nondeficiency (ND), Qi deficiency (QD), and Yin deficiency (YD). The ratio of subjects with carcinoembryonic antigen (CEA) was higher in YD pattern, and the ratio of subjects with carbohydrate antigen 19-9 (CA19-9) was higher both in YD and in QD, compared with ND. As a result of metabolomics analysis, twenty-five metabolites displayed differences between QD and ND, while twenty-eight metabolites displayed differences between YD and ND. The downregulated metabolites in QD/ND and YD/ND mainly include carbohydrates and the upregulated metabolites mainly include amino acids and fatty acids, suggesting conversion obstruction of carbohydrates, fatty acids, and amino acids occurs in patients with QD and YD compared with ND. Our results demonstrate that colorectal cancer patients with QD or YD were associated with metabolic disorders and the variations of serum metabolic profiles may serve as potential biochemical markers for diagnosis and prognosis of colorectal cancer patients displayed QD or YD patterns. Hindawi 2017 2017-07-24 /pmc/articles/PMC5546053/ /pubmed/28811829 http://dx.doi.org/10.1155/2017/7382752 Text en Copyright © 2017 Fangfang Tao et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Tao, Fangfang Lü, Ping Xu, Chunbo Zheng, Mengmeng Liu, Wenhong Shen, Minhe Ruan, Shanming Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome |
title | Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome |
title_full | Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome |
title_fullStr | Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome |
title_full_unstemmed | Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome |
title_short | Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome |
title_sort | metabolomics analysis for defining serum biochemical markers in colorectal cancer patients with qi deficiency syndrome or yin deficiency syndrome |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546053/ https://www.ncbi.nlm.nih.gov/pubmed/28811829 http://dx.doi.org/10.1155/2017/7382752 |
work_keys_str_mv | AT taofangfang metabolomicsanalysisfordefiningserumbiochemicalmarkersincolorectalcancerpatientswithqideficiencysyndromeoryindeficiencysyndrome AT luping metabolomicsanalysisfordefiningserumbiochemicalmarkersincolorectalcancerpatientswithqideficiencysyndromeoryindeficiencysyndrome AT xuchunbo metabolomicsanalysisfordefiningserumbiochemicalmarkersincolorectalcancerpatientswithqideficiencysyndromeoryindeficiencysyndrome AT zhengmengmeng metabolomicsanalysisfordefiningserumbiochemicalmarkersincolorectalcancerpatientswithqideficiencysyndromeoryindeficiencysyndrome AT liuwenhong metabolomicsanalysisfordefiningserumbiochemicalmarkersincolorectalcancerpatientswithqideficiencysyndromeoryindeficiencysyndrome AT shenminhe metabolomicsanalysisfordefiningserumbiochemicalmarkersincolorectalcancerpatientswithqideficiencysyndromeoryindeficiencysyndrome AT ruanshanming metabolomicsanalysisfordefiningserumbiochemicalmarkersincolorectalcancerpatientswithqideficiencysyndromeoryindeficiencysyndrome |